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Abstract
Vitamin C has been shown to delay the cellular senescence and was considered a candidate for chemoprevention and
cancer therapy. To understand the reported contrasting roles of vitamin C: growth-promoting in the primary cells and
growth-inhibiting in cancer cells, primary mouse embryonic fibroblasts (MEF) and their isogenic spontaneously
immortalized fibroblasts with unlimited cell division potential were used as the model pair. We used microarray gene
expression profiling to show that the immortalized MEF possess human cancer gene expression fingerprints including a
pattern of up-regulation of inflammatory response-related genes. Using the MEF model, we found that a physiological
treatment level of vitamin C (10
25 M), but not other unrelated antioxidants, enhanced cell growth. The growth-promoting
effect was associated with a pattern of enhanced expression of cell cycle- and cell division-related genes in both primary
and immortalized cells. In the immortalized MEF, physiological treatment levels of vitamin C also enhanced the expression
of immortalization-associated genes including a down-regulation of genes in the extracellular matrix functional category. In
contrast, confocal immunofluorescence imaging of the primary MEF suggested an increase in collagen IV protein upon
vitamin C treatment. Similar to the cancer cells, the growth-inhibitory effect of the redox-active form of vitamin C was
preferentially observed in immortalized MEF. All effects of vitamin C required its intracellular presence since the transporter-
deficient SVCT22/2 MEF did not respond to vitamin C. SVCT22/2 MEF divided and became immortalized readily
indicating little dependence on vitamin C for the cell division. Immortalized SVCT22/2 MEF required higher concentration
of vitamin C for the growth inhibition compared to the immortalized wildtype MEF suggesting an intracellular vitamin C
toxicity. The relevance of our observation in aging and human cancer prevention was discussed.
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Introduction
Vitamin C was first characterized as a coenzyme and a water-
soluble antioxidant. Additional biological activities of vitamin C
have been described subsequently. In primary cell culture, its
ability to promote growth was reported to be due to an
increased cell division and cell differentiation [1–4]. A related
property of vitamin C to delay senescence [5] and enhance
primary fibroblast reprogramming to pluripotency was further
demonstrated [6]. These in vitro observations made at
physiologically relevant concentrations of vitamin C (10
25 M)
are consistent with the results of in vivo studies. Patients with
premature aging disorder, Werner Syndrome, display acceler-
ated senescence in their fibroblasts [7] and develop rare forms of
cancer [8]. In a mouse model of Werner Syndrome, vitamin C
was found to promote normal growth and delay senescence [9].
In this paper, gene expression profiling and immunofluores-
cence imaging were conducted to facilitate the understanding of
molecular mechanisms mediating vitamin C-dependent growth
promotion.
Little is known about the effect of vitamin C, at physiologically
relevant conditions, on the growth of immortalized cells. Treating
cancer cells with pharmacological levels of vitamin C (10
24 M and
above) is known to lead to cell cycle arrest and apoptosis [10–12],
as well as gene expression changes [13]. While these observations
were used to support the chemotherapeutic potential of vitamin C,
a recent meta-analysis failed to conclude on the efficacy of vitamin
C [14]. Mutant mice that could not synthesize vitamin C
endogenously, a trait similar to humans [15], had more aggressive
growth of implanted tumor after vitamin C supplementation [16].
In vitro studies using pharmacological doses of vitamin C were
further complicated by the known free radical-generating
interaction between vitamin C and culture medium components
[17]. In this paper, vitamin C dose-dependent effects were
analyzed in immortalized cells using redox-active and -inactive
vitamin C. Gene expression profiles of primary and immortalized
cells were also compared after the same vitamin C treatment.
Mouse embryonic fibroblasts (MEF) were used as the cell model
in this study. The vitamin C-synthesizing ability of mouse is
limited to hepatocytes [18] so MEF mimic human cells in their
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spontaneous immortalization, thus allowing the comparison of a
single cell type at two phenotypes: primary MEF with limited
mitotic life span; and immortalized MEF. Immortalization is
considered a link between normal and tumorigenic cells [19,20].
The relevancy of immortalized MEF to certain human cancer was
previously discussed [21,22]. Fibroblasts also contribute to the
cancer stem cell niche [23] and thus the response of fibroblasts to
vitamin C could have additional implications. Besides the wildtype
MEF, MEF from embryos that do not express functional sodium-
dependent vitamin C transporter 2 (SVCT22/2) were also used
in the study to distinguish the effects of intracellular and
extracellular vitamin C.
Materials and Methods
Materials
L-[carboxyl-
14C]ascorbic acid (13 mCi/mmol) was purchased
from Amersham Biosciences (Buckingshire, England) and
[methyl-
3H]thymidine was from ICN Pharmaceuticals, Inc.
(Irvine, CA). L-ascorbic acid (SigmaUltra) and L-ascorbic acid 2-
phosphate (sesquimagnesium salt) were from Sigma Aldrich (St.
Louis, MO). D-(-)-isoascorbic acid (.99% pure) was from Fluka.
All cell culture reagents were from Invitrogen Corp. (Carlsbad,
CA) except characterized fetal bovine serum, which was purchased
from Hyclone, USA (Logan, UT). EcoLite
TM(+) was used as the
scintillation fluid (ICN Pharmaceuticals, Inc.). All other chemicals
used were analytical or molecular biology grade.
Mouse embryonic fibroblast generation, propagation
and treatment
All MEF were collected from a transgenic mouse colony
maintained in University at Buffalo specific pathogen-free facility
[24] following protocols approved by the Institutional Animal Care
and Use Committee. Embryos at ED 13.5 were used and
genotyping by PCR was described before [24]. Standard high-
glucose DMEM medium supplemented with penicillin, streptomy-
cin and 10% FBS was used for the culturing [25]. To enrich
fibroblasts, cells that were not attached to the flask surface after 1-
hour culturing were removed. MEF were immortalized by the
original 3T3 method [19] or a published limited medium method
[20]. Immortalization is characterized by an increase in the rate of
growth after a prolonged period of growth arrest and is associated
with the death of most cells and emergence of small numbers of
colonies [19]. We were able to consistently establish immortalized
MEF cell lines (N=18) and propagate them for more than 40
passages. Most experiments were repeated using MEF from
different embryos. Cell treatment was always started the day after
seeding, and carried out daily by adding stock solutions (dissolved in
phosphate buffered saline) to the growth medium. There was no
medium change between cell seeding and harvesting during cell
propagation experiment. Some experiments, when indicated, were
performed with MEFs propagated in T-25 flask from one passageto
the next consistently in the presence of 20 mM ascorbate 2-
phosphate. To determine the effect of vitamin C or indicated
chemicals on the cell growth, cells propagated with or without
vitamin C were harvested from their T-25 flasks and grown in 12-
well plates fortreatmentcomparison.Thetotalamountofprotein in
a monolayer was used to monitor cell growth. A modified Lowry
assay [26] with bovine serum albumin as the standard was used.
3H-thymidine incorporation
A modified
3H-thymidine incorporation [27] procedure was
used to determine cell division. Briefly, to perform the
3H-
thymidine incorporation experiment,
3H-thymidine (1 mCi per
well of 6-well plate) was added to the cell monolayer after a
medium change. After the 4-hour incorporation, the labeled DNA
in trichloroacetic acid-lysed cells was collected and the radioac-
tivity determined by the liquid scintillation counting using
Beckman coulter LS6500 Scintillation Counter. The incorporation
was specific as the negative control samples (addition of
3H-
thymidine without incubation) had only background radioactivity.
Vitamin C accumulation
The ability of MEF to take up ascorbic acid through sodium-
dependent and -independent pathways was determined by
14C-
ascorbate transport assay as previously described [28]. Briefly, cell
monolayers grown in 6-well culture plates were rinsed and
incubated with Hanks’ balanced salt solution in a 37uC incubator.
Hanks’ balanced salt solution containing N-methyl-glucamine
substituting sodium was used to determine sodium-independent
transport.
14C-ascorbate (10 mM) was added and the uptake was
terminated after 15 minute incubation by the removal of
14C-
ascorbate-containing Hanks’ balanced salt solution. Monolayers
were then rinsed three times with ice-cold phosphate buffer saline
before lysed by 0.5% SDS for the radioactivity and protein
measurements. Triplicate wells of cells were used for the transport
assay and the results represented the mean6SD of three
independent wells after normalization by total protein in each
well. Experiments were repeated with different passages of
wildtype and SVCT22/2 MEF and the results were similar.
Statistical analyses of cell samples
Statview and Super-ANOVA v.1.11 (Abacus Concepts Inc.,
Berkeley, CA) were used to analyze the measurement in total
protein, thymidine incorporation and vitamin C uptake. The
Student’s t-test was used to compare between two groups and one-
way ANOVA was performed along with Bonferroni/Dunn test for
the multiple comparison. Effects with p,0.05 were considered
significant.
Confocal imaging
Primary embryonic fibroblasts were grown on the glass
coverslips with 4-day treatment of phosphate-buffered saline
(vehicle) or 20 mM vitamin C. Cells were fixed with 4%
paraformaldehyde and then treated with 10% DMSO before the
antibody incubation. To visualize collagen IV, primary rabbit
anti-collagen IV antibody (sc-11360, Santa Cruz Biotechnology,
Inc.) was used in conjunction with Alexa FluorH 488 goat anti-
rabbit IgG (H+L) (A11008, Invitrogen Corp). To visualize F-actin
distribution, Alexa FluorH 568 phalloidin (A12380, Invitrogen
Corp.) was used. The manufacturer’s protocols (Invitrogen Corp.
Carlsbad, CA) were followed for the staining. A. Zeiss LSM510
confocal microscope with 636objective lens (UB Confocal and 3-
D imaging facility) was used to capture images and the same
confocal setting was used for the imaging of control and vitamin
C-treated MEF. Within each genotype, the control and treated
cells were from the same passage and processed at the same day
for imaging. Multiple images were acquired from triplicate cell
samples of the same genotype/treatment. Representative confocal
images were processed with Volocity 4.0.1 software (Perkin Elmer,
Inc.) to generate 3-D volumes and X-Z sections.
RNA isolation and microarray hybridization
P4 (representing the primary cells) and P32 (representing the
immortalized cells) of MEF were used for gene expression
profiling. There were four treatment groups: primary cells with
MEF Response to Physiological Levels of Vitamin C
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immortalized cells with or without 2-day 20 mM ascorbate 2-
phosphate treatment. Total RNA was extracted from triplicate cell
monolayers using MasterPure
TM RNA Purification Kit (Epicentre,
Madison, WI) following the manufacturer’s protocol. The quality of
RNA was determined by the OD260/OD280 ratio (greater than
1.9) and verified using Agilent 2100 bioanalyzer (Agilent Technol-
ogies, Santa Clara , CA). The concentration of RNA was
determined by OD260. Whole mouse genome 4644 K gene
expression single-color microarray kit (US00044437) [29] from the
same batch (Agilent Technologies, Santa Clara , CA), verified using
NCBI genome Build 32, was used for gene expression analysis
following the manufacturer’s protocol by Empire Genomics,
Buffalo, NY (an Agilent-certified facility). The Agilent array used
60mer oligonucleotide probes including positive and negative
controls as well as redundant detection of some transcripts at
different areas of the array using the same or different probes. All
twelve samples in the study were processed on the same day. They
were randomly assigned to three slides for hybridization.
Microarray Data analysis
Data analysis was performed on twelve arrays for four treatment
groups (N=3 per group, RNA samples from three independent
wells in each treatment group). The Lowess method was first used
for intensity-dependent normalization, and then followed by
global normalization of the probe expression level. The goal was
to adjust the median expression values of all arrays to the same
scale. One experimental array (immortalized MEF without
vitamin C treatment) was randomly selected as the baseline array
and its median value (~ m mbase) was used for the normalization of
remaining arrays: x
0
i~
~ m mbase
~ m mi
xi.
Only probes with expression levels above the mean of negative
controls in at least 50% of the samples were used for the statistical
comparison. The results of normalization and MA plots are
included as Figure S1. The regularized t-test [30], which is good
for limited numbers of replicates, was employed to detect
significantly treatment effects. For multiple test correction, the
false discovery rate (q-value,0.1) was controlled by adjusting the
p-values using the following formula:
q{value~
N   Pc
R
where N is the number of genes in the test, and R is the ascending
rankorderoftherespectivep-value atcertaincutoffPc. Astatistically
valid list of differentially expressed genes was then sorted based on
folds of treatment effect and grouped as shown in Tables 1–3. To
objectively determine the effect of treatment on functionally
cooperative genes, each group of DEGs was analyzed by the tools
in Database for Annotation, Visualization and Integrated Discovery
(DAVID; http://david.abcc.ncifcrf.gov/) version 6.7 [31,32]. This
functional annotation is to determine statistically significant over-
representation of functional categories due to each treatment. A
gene could belong to multiple functional categories.
qPCR validation of microarray analysis
cDNA was generated from total RNA by reverse transcription
using oligo-dT 15 primer (Promega, Madison, WI) and Omnis-
cript reverse transcriptase (Qiagen, Valencia, CA). Primers used
for qPCR were Adamts4: forward, AGCAAGCAGTCGGG-
CTCCTT, reverse, GCGTAAGAACCGTCAGAAAG; CNN1:
forward, TGCGAATTTATCAACAAGCTG C, reverse, CCC-
CATACTTGGTAATGGCTTTG; Csf1: forward, 5GAGCAG-
GAGTATTGCCAAG, reverse GCCTTCTTTAGGTAGCAA-
ACAG; Igf2: forward, GTGCTGCATCGCTGCTTAC, reverse,
ACGTCCCTCTCGGACTTGG; MmP13: forward, GTGAT-
GATGATGATGATGACCTG, reverse, GCATTTCTCGGAG-
CCTGTC; Ptprdf1: forward, CTGCTCTCGTGATGCTTG-
GTT, reverse, ATCCACGTAATTCGAGGCTTG.
Quantitative PCR reaction was performed in MyiQ iCycler
(UB Confocal and 3-D imaging facility) using SsoAdvanced SYBR
Green Supermix (Bio-Rad Labs, Richmond, CA) and the
expression of GAPDH was used for normalization (forward,
ATCCCATCACCATCTTCCAG, reverse, GCCATCACGCC-
ACAGTTTCC). Similar to the microarray analysis, triplicates
(three independent wells of cells) were used for the qPCR analyses.
The correlation between the fold changes from microarray
analysis and from qPCR is shown in the Figure S2 (r=0.997).
Table 1. Summary of the effect of vitamin C treatment on the gene expression of primary mouse embryonic fibroblasts as
determined by gene expression microarray analysis
a.
Degree of effect Number of probes affected
b Gene expression profiling for functional enrichment
c
p,0.01
q expression 1575
Q expression 225
p,0.01, .1.5-fold effect
q expression 219 (205) Cell cycle (13) p=9.1E-3
Cell division (10) p=3.4E-3
Q expression 109 (108)
p,0.01, .3-fold effect
q expression 0
Q expression 4 (4)
aThe passage 4 primary embryonic fibroblasts were treated with 20 mM ascorbate 2-phosphate for 2 days before RNA harvesting. The gene expression level in the
vitamin C-treated primary MEF was divided by the level in the untreated primary MEF to obtain the fold change.
bVitamin C treatment significantly affected the expression of these probes/genes. Multiple probes may be used to quantify the expression of the same gene. The
number in the parenthesis represents the number of genes affected.
cp value shown is Benjamini.
doi:10.1371/journal.pone.0032957.t001
MEF Response to Physiological Levels of Vitamin C
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Physiological level vitamin C, but not other antioxidants,
promotes the growth of primary MEF
The effect of vitamin C on the growth of primary MEF is shown
in Fig. 1. To prevent pro-oxidant activity due to the interaction of
ascorbic acid with medium components [17], a previously
characterized pro-drug form of vitamin C [1], ascorbate 2-
phosphate, was used for the supplement throughout the study
unless indicated otherwise. As shown in Fig. 1A, dose-dependent
effects were observed, and 10 and 20 mM supplementation led to a
consistent increase in total cellular protein starting two days after
the initiation of treatment. The concentration range was chosen
because 10 mM is the minimal plasma concentration required for
the prevention of clinical vitamin C deficiency. As shown in
Fig. 1B, two-day treatment with 10 or 20 mM vitamin C
significantly increased thymidine incorporation. Thus, increasing
cell division contributed to the growth promotion by vitamin C.
The growth-promotion by vitamin C can be observed throughout
the serial passaging of primary MEF (Fig. 1C). Briefly, MEF
Table 2. Summary of the effect of immortalization on the gene expression of mouse embryonic fibroblasts as determined by gene
expression microarray analysis
a.
Degree of effect Number of probes affected
b Gene expression profiling for functional enrichment
c
p,0.01
q expression 4810
Q expression 4210
p,0.01, .1.5-fold effect
q expression 3968
Q expression 3343
p,0.01, .3-fold effect
q expression 1147 (945) Glycoprotein (218)
Inflammatory response (30)
Q expression 1319 (1011) Glycoprotein (284)
Extracellular matrix (55)
Tissue morphogenesis (37)
aThe expression level of genes in the untreated immortalizaed (passage 32) MEF was divided by levels in the untreated primary (passage 4) MEF to obtain fold changes.
bImmortalization significantly affected the expression of these probes/genes. Multiple probes may be used to quantify the expression of the same gene. The number in
the parenthesis represents the number of genes affected.
cp value shown is Benjamini.
doi:10.1371/journal.pone.0032957.t002
Table 3. Summary of the effect of vitamin C treatment on the gene expression of immortalized mouse embryonic fibroblasts as
determined by gene expression microarray analysis
a.
Degree of effect Number of probes affected
b Gene expression profiling for functional enrichment
c
p,0.01
q expression 1844
Q expression 1276
p,0.01, .1.5-fold effect
q expression 1284 (1048) Cell cycle (99) p=3.0E-26
Cell division (59) p=1.0E-23
Q expression 1060 (840) Extracell matrix(63)p=1.5E-26
Cell adhesion (57) p=2.4E-10
Collagen (21) p=2.9E-10
p,0.01, .3-fold effect
q expression 97 (88)
Q expression 276 (229) Extracell matrix(31)p=3.5E-19
aImmortalized embryonic fibroblasts (p32) were treated with 20 mM ascorbate 2-phosphate for 2 days before RNA harvesting. The gene expression level in the vitamin
C-treated immortalized wildtype MEF was divided by the level in the untreated immortalized wildtype MEF to obtain the fold change.
bVitamin C treatment significantly affected the expression of these probes/genes. Multiple probes may be used to quantify the expression of the same gene. The
number in the parenthesis represents the number of genes affected.
cp value shown is Benjamini.
doi:10.1371/journal.pone.0032957.t003
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passage to seed into 12-well plates for the experiment. The MEF
were treated with vehicle or 20 mM ascorbate 2-phosphate. In
addition, MEF were also propagated in T-25 flasks with 20 mM
ascorbate 2-phosphate in the medium (Fig. 1D). At each indicated
passage, cells were harvested from the T-25 flask and seeded into
12-well plates for the experiment. Similar to the cells in Fig. 1C,
cells in 12-well plates were treated with vehicle or 20 mM
ascorbate 2-phosphate. Similar to the cells in Fig. 1C, 20 mM
ascorbate 2-phosphate treatment increased cell growth at every
passage (Fig. 1D).
As shown in Fig. 1E and 1F, 20 mM ascorbic acid or 20 mM
isoascorbic acid also significantly increased the total cellular
protein after four days of treatment. At higher concentration
(100 mM), the growth-promoting effect disappeared for ascorbate
2-phosphate and ascorbic acid, and isoascorbate slightly inhibited
the growth (Fig. 1G). Although vitamin C is known as an
antioxidant, primary MEF treated with other structurally
unrelated antioxidants, (-)-epigallocatechin-3-gallate (0.01–1 mM)
(Fig. 1H) and vitamin E (1–10 mM) [33], did not show any increase
in total cellular protein. Control MEF and MEF treated with
20 mM ascorbate 2-phosphate for four days showed no differences
Figure 1. Dose- and treatment duration-dependent effect of vitamin C and its analogs on primary mouse embryonic fibroblasts.
Cells propagated in normal medium at low passages (before passage 6 except 1E and 1F) were used for the study. They were seeded in cell culture
wells at 2610
4 cells/cm
2 and treated every day starting the day after seeding. They were harvested 24 hours after the last treatment. There was no
medium change from cell seeding to the end of ascorbate 2-phopshate treatment. The medium was changed before the start of the thymidine
incorporation experiment as a part of the experimental procedure. (A) Effect of 1–4 days of treatment with 5–20 mM ascorbate 2-phosphate on total
protein; (B) Effect of 1–2 days of treatment with 5–20 mM ascorbate 2-phosphate on thymidine incorporation; (C)(D) Passage-dependent effect of
ascorbate 2-phosphate on mouse embryonic fibroblasts propogated in the absence (C) or presence (D) of 20 mM ascorbate 2-phosphate; (E) (F) Effect
of 4-day treatment of 20 mM ascorbic acid (E) or 20 mM isoascorbate (F) on total protein; (G–I) Effect of 4-day treatment of (G) 100 mM vitamin C or
analog, (H) 0.01–1 mM (-)-epigallocatechin-3-gallate (EGCG), or (I) 1–10 mM alpha-tocopherol succinate (Vit E) on total protein. All data shown
represent means6S.D. of 3–4 independent wells. *significantly different from the control cells without treatment at p,0.05.
doi:10.1371/journal.pone.0032957.g001
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(results not shown).
Confocal immunofluorescene imaging analysis of vitamin
C-treated MEF
One major function of vitamin C is to assist the post-
translational modification of collagen. Collagen IV is mainly
found in the basement membrane [34] where fibroblasts reside
and function [35]. To determine the effect of vitamin C on
intracellular collagen IV protein level, primary MEF (p4) were
grown in the absence (Fig. 2, top row) or presence (Fig. 2, bottom
row) of 20 mM vitamin C, over four days of treatment. Compared
to the untreated MEF of the same passage, intracellular collagen
appeared more prominent with the vitamin C treatment especially
in the X-Z section (Fig. 2 compared the top and bottom rows). In
contrast, F-actin, a component of cytoskeleton, did not appear to
increase in vitamin C-treated cells (Fig. 2). MEF also gained cell
height upon vitamin C treatment (Fig. 2, X-Z sections), which can
contribute to the increase in total protein observed in Fig. 1A and
C–F.
Using vitamin C transporter-null MEF to confirm the role
of intracellular vitamin C in the growth of primary MEF
To demonstrate the importance of intracellular vitamin C for
the effects shown in Figs. 1 and 2, sodium-dependent vitamin C
transporter (SVCT2)-null MEF was used for comparison (Fig. 3).
Vitamin C is made in hepatocytes of vitamin C-synthesizing
species such as mice and its distribution to extrahepatic tissues
mostly depends on cellular SVCT2 [36]. SVCT1 is not known to
be expressed in the fibroblasts [37] and we did not detect the
presence of SVCT1 in our MEF either (results not shown).
SVCT22/2 MEF did not have sodium-dependent vitamin C
transport activity (Fig. 3A) but did show limited sodium-
independent vitamin C transport activity similar to the
SVCT2+/+ MEF (Fig. 3A). SVCT2-null embryonic fibroblasts
grow well indicating that the need of vitamin C for cell division is
minimal. Different from SVCT2+/+ MEF, SVCT22/2 MEF
showed no increase in the total protein (Fig. 3B); nor in the
thymidine incorporation after 20 mM vitamin C treatment
(Fig. 3C). This lack of response to vitamin C treatment persisted
throughout the serial passaging of SVCT22/2 MEF (Fig. 3D)
and at 20, 70 and 100 mM of ascorbate 2-phosphate treatment
(Fig. 3E). In contrast, the growth inhibitory effect of 100 mM
vitamin E observed in wildtype MEF (Fig. 1I) was similarly found
in SVCT22/2 MEF (Fig. 3F). In confocal immunofluorescence
study, treatment of SVCT22/2 MEF with 20 mM vitamin C for
4 days also did not increase the cell height (Fig. 4, X-Z sections),
which is consistent with the lack of increase in total protein after
vitamin C treatment (Fig. 3B and D, E). Based on the results in
Figs. 3 and 4, intracellular vitamin C accumulation is needed to
realize the growth-promoting effect of vitamin C.
Vitamin C and the gene expression in wildtype primary
MEF
Microarray analysis was performed to determine whether two
days of vitamin C treatment affected the expression of cell growth-
related genes. We chose the duration because two days of
treatment with 20 mM vitamin C was sufficient to increase total
protein and thymidine incorporation significantly (Fig. 1A, B). The
treatment did lead to changes in gene expression (Table 1). Of the
genes that showed significant overexpression at greater than 1.5
fold, we performed functional annotation using DAVID and found
enrichment in cell cycle (13 genes) and cell division (10 genes)
functional categories. A complete list of these genes is included in
the Table S1. Of these, four genes, Asp (abnormal spindle)-like,
cell division cycle 25C, cyclin B1, and RAD15 homolog, were
previously found to increase in expression (2.5–2.9 folds) when
primary human skin fibroblasts were treated with 100 mMo f
ascorbate 2-phosphate for five days [38]. Results from the gene
expression analysis is consistent with the thymidine incorporation
finding in Fig. 1B that vitamin C treatment of the primary MEF
increased cell division.
MEF immortalization and gene expression profiling of
the immortalized MEF
Wildtype and SVCT22/2 MEF reached immortalization
similarly (Fig. 5A and B). This observation again indicated a lack
of significant need of vitamin C by the cell division machinery.
Immortalization was associated with significant gene expression
changes (Table 2). Functional annotation revealed that among the
genes that over-expressed greater than 3-fold, there was
enrichment in genes that represent glycoproteins (218 genes) and
genes involved in the inflammatory response (30 genes). A
complete list of these up-regulated genes is included in the
supplemental material (Table S2). Of the genes showed more than
a 3-fold decrease in expression in immortalized MEF compared to
the primary MEF (Table 2), enrichment of glycoproteins (284
genes) was also observed. In addition, down-regulation of genes
related to the extracellular matrix (55 genes) was also significant. A
complete list of the down-regulated genes is included in the
supplemental material (Table S3).
Effect of vitamin C on the growth of immortalized MEF
The immortalized MEF grew slowly initially but small growth-
promoting effect of vitamin C was consistently observed starting
passage 11 (Fig. 6A). This vitamin C treatment-induced increase in
total protein was less than those observed in primary MEF (Fig. 6A
vs. 1C, 1D). The growth-promoting effect of vitamin C was also
dose-dependent (Fig. 6B & 6C). The growth-inhibitory effect
observed at higher free ascorbate concentrations (Fig. 6C) is
Figure 2. Confocal immunofluorescence visualization of colla-
gen IV and ß-actin expression in primary embryonic fibroblasts
with (bottom row) and without (top row) 4-day ascorbate 2-
phosphate treatment. There was no medium change between cell
seeding and harvesting for staining. Composite confocal images of cells
stained for collagen IV (second column) and F-actin (third column) were
merged (first column) and images of X-Z sections were captured. The
size of the merged X-Y image was 140 mm6140 mm. The X-Z section
was taken from a stack of thirty-five 0.46 mm slices.
doi:10.1371/journal.pone.0032957.g002
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ascorbate in cancer cells [11,39,40]. The biphasic effect of vitamin
C was also observed in an unrelated line of human colon cancer
cells, Caco2. Ascorbate 2-phosphate at 40 mM showed growth-
promoting effect while ascorbate, the redox active form, at 40 mM
or higher inhibited cell growth (results not shown). Immortalized
SVCT22/2 MEF, as predicted from its lack of ability to acquire
vitamin C from medium (Fig. 3A), showed no response to
physiological treatment levels of vitamin C (Fig. 6D). Also,
different from the wildtype MEF, immortalized SVCT22/2
MEF was not sensitive to the inhibition by 100 mM free ascorbate
and was only slightly inhibited by 100 mM isoascorbate in the
medium (comparing Fig. 6C to 6E, also 6F). As shown in Fig. 6F,
300 mM ascorbate and isoascorbate were needed to reach the
same degree of inhibition in immortalized SVCT22/2 MEF
(open bar). The inhibition at 300 mM could be a result of a free
radical-generating interaction between ascorbate and isoascorbate
with medium components [11,39,40] because 300 mM non-redox
ascorbate 2-phosphate had minimal effect on immortalized
SVCT22/2 MEF (Fig. 6F). At 1 mM, ascorbate and ascorbate
2-phosphate treatments led to more inhibition of cell growth in
both cell types which is consistent with the widely reported dose-
dependent growth inhibition by vitamin C at 10
24 to 10
23 M (for
example, [13]).
Effect of vitamin C on the gene expression of
immortalized MEF
Treatment of immortalized wildtype MEF with physiological
levels of vitamin C was also associated with gene expression
changes (Table 3). A summarized comparison between the
responses of primary and immortalized MEF to the treatment of
vitamin C is included in Figure S3. For genes that showed at least
1.5 fold significant increase in expression, functional annotation
revealed that there was enrichment in genes involved in cell cycle
(99 genes) and cell division (59 genes). A complete list of these up-
Figure 3. Vitamin C in the medium does not affect SVCT22/2 embryonic fibroblasts. (A) SVCT22/2 fibroblasts do not have sodium-
dependent vitamin C transport activity. ND: determined but not detected. (B,C) SVCT22/2 fibroblasts do not show vitamin C treatment-dependent
increase in (B) total protein (measured after 4-day treatment with 20 mM ascorbate 2-phosphate) or (C) thymidine incorporation (measured after 2-
day treatment with 20 mM ascorbate 2-phosphate). There was no medium change from cell seeding to the end of ascorbate 2-phopshate treatment.
The medium was changed before the start of the thymidine incorporation experiment as a part of the experimental procedure. Unlike the wildtype
fibroblasts, SVCT22/2 fibroblasts did not show (D) passage-dependent; or (E) dose-dependent response to ascorbate 2-phosphate in the medium;
but did display (F) dose-dependent response to vitamin E in the medium. All data shown represent means6S.D. of 3–4 independent wells.
*significantly different from control cells without treatment at p,0.05.
doi:10.1371/journal.pone.0032957.g003
Figure 4. Confocal immunofluorescence visualization of colla-
gen IV and ß-actin expression in primary SVCT22/2 embryonic
fibroblasts with (bottom row) and without (top row) 4-day
ascorbate 2-phosphate treatment. There was no medium change
between the cell seeding and harvesting for staining. Composite
confocal images of cells stained for collagen IV (second column) and F-
actin (third column) were merged (first column) and images of X-Z
section were captured. The size of the merged X-Y image was
140 mm6140 mm. The X-Z section was from a stack of thirty-five
0.46 mm slices.
doi:10.1371/journal.pone.0032957.g004
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S4). This enrichment shared a similarity with the gene expression
pattern of primary MEF after vitamin C treatment (Table 1).
Interestingly, up-regulation was observed for Asp (abnormal
spindle)-like, cell division cycle 25C, cyclin B1, and RAD15
homolog, the same four genes that showed increases after vitamin
C treatment of primary human skin fibroblasts [38] and primary
MEF (Table 1). For the genes that showed at least 1.5-fold
significant decrease in expression in response to 20 mM vitamin C
treatment, there was enrichment in genes relating to extracellular
matrix (63 genes), cell adhesion (57 genes) and collagen (21 genes).
A complete list of genes that were significantly down-regulated by
vitamin C in immortalized MEF is included in the supplemental
material (Table S5). There were 31 genes in the extracellular
matrix functional category that showed at least 3-fold down-
regulation in immortalized MEF after physiological levels of
vitamin C treatment (last row of Table 3). A list of the genes is also
included in the supplemental material (Table S5). When the results
in Table 3 were compared to the results in Table 2, we found that
the immortalization process and vitamin C treatment of
immortalized MEF were similarly associated with a decreased
expression of extracellular matrix genes. To examine if vitamin C
Figure 5. The immortalization of wildtype and SVCT22/2 fibroblasts. Wildtype and SVCT22/2 mouse embryonic fibroblasts were carried
to beyond immortalization following the published limited medium method [20]. The immortalization process was associated with (A) a significant
increase in days to reach confluence around passage 11. Once immortalized, MEF regained rapid cell division. (B) Saturation density was higher in
both wildtype and SVCT22/2 primary fibroblasts compared to their respective immortalized fibroblasts.
doi:10.1371/journal.pone.0032957.g005
Figure 6. The effect of vitamin C treatment on immortalized wildtype and SVCT22/2 fibroblasts. (A) The effect of 4-day 20 mM
ascorbate 2-phosphate treatment on the total protein of immortalized wildtype fibroblasts. (B,C) Dose-dependent effect of 4-day treatment with (B)
ascorbte 2-phosphate and (C) ascorbate on the immortalized wildtype fibroblasts. (D) Immortalized SVCT22/2 MEF did not respond to 4-day 20 mM
ascorbate 2-phosphate treatment. (E) Immortalized SVCT22/2 fibroblasts were inhibited only by 4-day 100 mM isoascorbate treatment. (F)
Immortalized wildtype fibroblasts were more sensitive to the inhibitory effect of pharmacological concentrations of vitamin C and analog compared
to immortalized SVCT22/2 fibroblasts (4-day treatment). All data shown represent means6S.D. of 3–4 independent wells. Some values and error
bars are too small to be clearly visible on the graph. *significantly different from the control cells without treatment at p,0.05.
doi:10.1371/journal.pone.0032957.g006
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genes that were increased by the immortalization, 20 genes that
showed the greatest over-expression upon immortalization were
compiled (Table 4). Most of these genes or their family members
were also found to be over-expressed in human cancers [41–56].
These genes had a mean signal level of 1236289 as primary MEF
(ranging from 8-1173), which was higher than the signal level of
the negative control in the array (around 5). As shown in the last
column of Table 4, vitamin C treatment led to further increase in
the expression of some genes but not all. Two genes, Cyp2f2 and
Sp100, that increased expression upon immortalization, showed
less expression in vitamin C-treated immortalized MEF. Although
genes involved in protein synthesis were found to be affected by
300–800 mM vitamin C treatment [13], under our physiological
treatment condition (20 mM ascorbate 2-phosphate), genes
involved in protein systhesis were not affected in primary or
immortalized MEF. This observed difference is not surprising as
growth inhibition was observed by Belin et al at high concentra-
tions [13] whereas our treatment showed growth stimulation (Fig. 1
and 6). In summary, vitamin C treatment of immortalized MEF
led to changes that were in the same direction as the changes
observed in the immortalization process.
Discussion
Mouse embryonic fibroblasts were used in this study as a model
to determine the effect of vitamin C under two phenotypes:
primary cells; and spontaneously immortalized cells with unlimited
renewal potential. In summary, our gene expression profiling
provided new evidences on the presence of unique cancer-like
fingerprints in immortalized MEF and thus supports the usefulness
of MEF model in evaluating phenotype-dependent and -
independent effects. Additionally, our focus on the physiological
level of vitamin C led to new insights since previous vitamin C
studies on cells largely aimed at the pharmacological effect.
The presence of immortalization-associated genetic hallmark in
immortalized embryonic fibroblasts and human cancers was
previously considered [21,22,57]. The results of our gene
expression profiling further support the relationship. Of the top
20 most over-expressed genes in immortalized MEF (Table 4),
most genes belong to families that have been shown to over-
express in human cancer [41–56]. In fact, Naalad2 belongs to the
same gene family as the prostate cancer biomarker, prostate-
specific antigen [43]. An increase in the inflammatory response
was found during cancer development and progression [58–64].
Our gene expression profiling revealed an up-regulation in the
inflammatory response in immortalized MEF in the absence of
immune cells (Table 2, Table S2). Also observed in the absence of
immune cells was the up-regulation of chemokine (C-C motif)
ligand, C-type lectin domain family member, and the killer cell
lectin-like receptors (Table 4), players in the innate immune
response [65–67]. A change in the stromal-epithelial crosstalk is
another hallmark during human carcinogenesis [68,69]. As
expected, in immortalized MEF, an overall enrichment of
Table 4. Effect of vitamin C treatment on the 20 genes that had maximal increase in expression upon immortalization in mouse
embryonic fibroblasts (MEF).
Fold of changes in expression
a
Gene Gene description Immortalization
b vitamin C
c
Plf2 proliferin 2 5985 (p=1.5E-06) 2.85 (p=0.002)
Mrpplf4 mitogen regulated protein, proliferin 4 2863 (p=1.9E-06) 2.37 (p=0.004)
Car8
d carbonic anhydrase 8 67 (p=7.7E-06) 1.65 (p=0.004)
Trim30 tripartite motif protein 30 66 (p=3.9E-05) -
Ccl6 chemokine (C-C motif) ligand 6 64 (p=0.0006) 1.84 (p=0.002)
Naalad2 N-acetylated alpha-linked acidic dipeptidase 2 58 (p=2.9E-05) -
Cst6 cystatin E/M 57 (p=3.7E-07) -
Cyp2f2 cytochrome P450, family 2-f, polypeptide 2 56 (p=5.5E-05) 22.37 (p=0.007)
Sp100 nuclear antigen Sp100 53 (p=2.5E-05) 21.71 (p=0.0006)
Klra7 killer cell lectin-like receptor, subfamily A-7 48 (p=2.9E-06) 1.95 (p=0.002)
Plxdc1 plexin domain containing 1 47 (p=3.9E-07) -
Kcnc2 potassium voltage gated channel, Shaw-related 2 43 (p=4.2E-05) -
Duoxa1 dual oxidase maturation factor 1 42 (p=8.8E-06) -
Hsd3b2 hydroxysteroid dehydrogenase-2, d3b2 41 (p=5.4E-05) 4.20 (p=0.001)
Klra22 killer cell lectin-like receptor subfamily A-22 38 (p=1.6E-05) 1.84 (p=0.008)
Klra15 killer cell lectin-like receptor, subfamily A-15 36 (p=1.1E-05) 2.13 (p=0.001)
Gdf10 growth differentiation factor 10 35 (p=0.0004) -
Add2 adducin 2 35 (p=1.9E-05) 2.74 (p=0.0002)
Klra12 killer cell lectin-like receptor subfamily A-12 35 (p=2.1E-06) 2.06 (p=0.008)
Clec4e C-type lectin domain family 4-e 34 (p=1.9E-05) -
aAll effects shown had p,0.05. -: no significant effect was detected.
bThe gene expression level of untreated immortalizaed MEF (p32) was divided by the respective expression level of untreated primary MEF (p4).
cCells were treated with 20 mM ascorbate 2-phosphate for 2 days before RNA harvesting. The gene expression level of vitamin C-treated immortalized MEF (p32) was
divided by the respective expression level of untreated immortalized MEF (p32).
dGenes with bold letters are known to have increased expression in human cancers.
doi:10.1371/journal.pone.0032957.t004
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found among genes that were affected (increased or decreased).
Specifically, immortalization led to a down-regulation of genes
belonging to the extracellular matrix functional category. Also,
similar to the cancer cells [40], immortalized MEF are more
sensitive to the pro-oxidant toxicity of vitamin C than the primary
MEF (Fig. 1G vs. 6C). Overall, our findings support the use of
primary and immortalized mouse embryonic fibroblast model pair
to understand the role of physiological level vitamin C in normal
and malignant cells. The utility of this model pair for other studies
remains to be explored.
Scurvy is typically manifested at plasma concentration of
vitamin C less than 12 mM. In this study, 5–20 mM was used to
determine the physiological effects of vitamin C. Dose- and
treatment duration-dependent increases in total protein and
thymidine incorporation were observed in primary MEF (Fig. 1).
Vitamin C is critical for normal growth [70] and similar growth
promotion by vitamin C in vitro was previously reported for other
primary cells [1–4]. This property is likely independent of the
antioxidant activity of vitamin C (Fig. 1). Instead, an increase in
collagen accumulation (Fig. 2) as well as an up-regulation of cell
cycle and cell division-related genes (Table 1) could be the
mechanisms stimulating growth. Intracellular vitamin C is needed
since SVCT22/2 MEF did not respond to vitamin C treatment
(Fig. 3B–E). The immortalized MEF also showed increased growth
in response to physiological levels of vitamin C treatment (Fig. 6).
Similar to the primary cells, a pattern of up-regulation of cell
cycle- and cell division-related genes were observed (Table 3).
With the massive change during immortalization (Table 2), it is
not surprising that despite a similar pattern of responses in primary
and immortalized MEF to the vitamin C treatment, the genes
affected were not identical as shown in the Figure S3.
Immortalized MEF had more genes affected by vitamin C than
primary MEF (Table 1 compared to Table 3, Fig. S3).
Physiological levels of vitamin C also further increased the
expression of some immortalization-related genes (Tables 3 and
4), although not all. While increasing collagen in primary cells
(Fig. 2), vitamin C decreased the expression of genes in the
extracellular matrix functional category including some collagen
genes in immortalized MEF (Table 3 and S5). This change is
noteworthy as the immortalization process was found to link to a
decreased extracellular matrix gene expression including some
collagen genes (Table 2 and S3). The cell growth and gene
expression results collectively suggest that vitamin C may not be
ideal for chemoprevention. Although one allele of SVCT2 was
found to be associated with a lower risk for colorectal cancer [69],
the in vivo growth-promoting effect of oral vitamin C on
implanted cancer cells was reported in the Gulo2/2mice that
require dietary vitamin C similar to human [16]. Furthermore, the
biphasic effect of vitamin C, growth promotion at the lower level
and growth inhibition at higher concentration, can explain why a
recent meta-analysis failed to conclude on the clinical efficacy of
vitamin C in cancer treatment [14].
Conclusions
The immortalization of mouse embryonic fibroblasts (MEF) was
found to lead to similar gene expression pattern changes as in
human cancer. The presence of the cancer fingerprints suggests
the usefulness of the primary and immortalized MEF as a model
pair in the understanding of cellular phenotype-dependent and -
independent responses. As shown in cell growth analysis and gene
expression profiling, intracellular vitamin C promotes the renewal
of both primary and immortalized MEF. This could be the
mechanism behind the in vivo anti-aging activity of vitamin C in a
mouse model of Werner Syndrome, a condition characterized by
premature aging [9]. Broader effects of vitamin C on growth and
renewal are likely. A recent publication showed a promotion of
myogenic differentiation by vitamin C under otherwise non-
permissive temperature [71].
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Figure S1 Quality control of our microarray data by
intensity-dependent normalization (Lowess method)
and global normalization prior to the statistic analysis.
(TIF)
Figure S2 The correlation between qPCR and micro-
array in detecting the changes in the expression of six
genes (r=0.997).
(TIF)
Figure S3 Venn diagrams for the effect of two-day
20 mM ascorbate 2-phosphate treatment on the gene
expression of primary and immortalized mouse embry-
onic fibroblasts. (Top) Number of genes showed significantly
(p,0.01) increased expression after vitamin C treatment. (Bottom)
Number of genes showed significantly (p,0.01) decreased
expression after vitamin C treatment.
(TIF)
Table S1 Functional annotation of genes that are
significantly up-regulated by vitamin C for at least 1.5
folds in primary mouse embryonic fibroblasts.
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Table S2 Functional annotation of genes that are
significantly up-regulated for at least 3 folds in immor-
talized mouse embryonic fibroblasts (MEF) compared to
the primary MEF.
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Table S3 Functional annotation of genes that are
significantly down-regulated for at least 3 folds in
immortalized mouse embryonic fibroblasts (MEF) com-
pared to the primary MEF.
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Table S4 Functional annotation of genes that are
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